Exozymes EXOZ
NASDAQ EXOZ
$7.04 +0.64 (+10.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

Exozymes (EXOZ) Restructuring Costs (2023 - 2026)

Exozymes (EXOZ) posted quarterly Restructuring Costs of $152206.0 for Q4 2025, up 15.0% year-over-year from $132358.0 in Q4 2024, and down 28.94% quarter-over-quarter from $214181.0 in Q3 2025.

Exozymes (EXOZ) Restructuring Costs (2023 - 2026) Analysis & Trends

Exozymes (EXOZ) has reported Restructuring Costs for 3 consecutive years, with $152206.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Restructuring Costs rose 15.0% year-over-year to $152206.0; the TTM figure through Dec 2025 stood at $836072.0 (up 153.62% YoY), while the FY2025 annual figure was $836076.0, up 153.62% from the prior year.
  • Restructuring Costs retreated to $152206.0 in Q4 2025 per EXOZ's latest filing, from $214181.0 in the prior quarter.
  • Across five years, Restructuring Costs topped out at $265449.0 in Q2 2025 and bottomed at $56940.0 in Q3 2024.
  • Historically, Restructuring Costs has averaged $138726.8 across 3 years, with a median of $138801.0 in 2023.
  • Annual changes were most pronounced in 2024 — Restructuring Costs sank 60.8% — and 2025, when it jumped 342.53%.
  • Exozymes' Restructuring Costs stood at $76292.0 in 2023, then jumped by 73.49% to $132358.0 in 2024, then advanced by 15.0% to $152206.0 in 2025.
  • Business Quant data shows EXOZ's Restructuring Costs at $152206.0 in Q4 2025, $214181.0 in Q3 2025, and $265449.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn
10 Exozymes 61.53 Mn 61.53 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 161,422.00
Dec 31, 2025 152,206.00
Sep 30, 2025 214,181.00
Jun 30, 2025 265,449.00
Mar 31, 2025 204,236.00
Dec 31, 2024 132,358.00
Sep 30, 2024 56,940.00
Jun 30, 2024 59,985.00
Mar 31, 2024 80,377.00
Dec 31, 2023 76,292.00
Sep 30, 2023 145,244.00